Works matching IS 15430790 AND DT 2020 AND VI 18 AND IP 12
Results: 7
Circulating Tumor DNA as a Marker of Minimal Residual Disease in Colorectal Cancer.
- Published in:
- Clinical Advances in Hematology & Oncology, 2020, v. 18, n. 12, p. 791
- By:
- Publication type:
- Article
Transfusion Replacement Strategies in Jehovah's Witnesses and Others Who Decline Blood Products.
- Published in:
- Clinical Advances in Hematology & Oncology, 2020, v. 18, n. 12, p. 826
- By:
- Publication type:
- Article
A Closer Look at Tazemetostat.
- Published in:
- Clinical Advances in Hematology & Oncology, 2020, v. 18, n. 12, p. 820
- By:
- Publication type:
- Article
PARP Inhibitors in Prostate Cancer: Practical Guidance for Busy Clinicians.
- Published in:
- Clinical Advances in Hematology & Oncology, 2020, v. 18, n. 12, p. 808
- By:
- Publication type:
- Article
Novel Therapies for Triple-Negative Breast Cancer.
- Published in:
- Clinical Advances in Hematology & Oncology, 2020, v. 18, n. 12, p. 799
- By:
- Publication type:
- Article
Choosing Between Novel Agents and Chemoimmunotherapy in CLL.
- Published in:
- Clinical Advances in Hematology & Oncology, 2020, v. 18, n. 12, p. 780
- By:
- Publication type:
- Article
The Year of Living Stressfully.
- Published in:
- Clinical Advances in Hematology & Oncology, 2020, v. 18, n. 12, p. 762
- By:
- Publication type:
- Article